alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
1 In The



### Court of Appeals

Ninth District of Texas at Beaumont

____________________

NO

. 09

- 1 5

- 00 153

- C V



### ____________________

IN THE INTEREST OF E.R.L.

________________________________________ _______________ ______________

On A ppeal from the 317th District Court

Jefferson County, Texas

Trial Cause No

. C

- 222,601

________________________________________ ________________ _____________

MEMORANDUM OPINION

The appellant and the Office of the Attorney General of Texas (OAG) filed a

joint motion for reversal and remand of the order denying the appellant’s petition

to challenge acknowle dgement of paternity. The appellant and the OAG agree that,

in the interest of justice, the case should be remanded to the trial court for gene tic

testing

. See Tex. R. App . P. 42.1(a)(2)(B). They further request that each party be

ordered to bear its own costs. Id. The custodial parent neither filed a notice of

appeal nor filed an objection to the joint motion for reversal and remand. We

vacate t he judgment of the trial court without regard to the merits and remand the

cause to the trial court for further proceedings

.2

VACATED AND REMANDED.

________________________________ LEANNE JOHNSON

Justice

Submitted on November 24, 2015

Opinion Delivered November 25, 2015

Before Kreger, Horton, and Johnson, JJ.
[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Page 44822]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20493]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of Allergy, Immunology, 
and Transplantation Research Committee.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Allergy, Immunology, and Transplantation 
Research Committee.
    Date: October 19-20, 2017.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities/Room 3G31B National Institutes of Health, NIAID, 5601 
Fishers Lane MSC 9834, Bethesda, MD 20892-9834, (240) 669-5060, 
<a href="/cdn-cgi/l/email-protection#bbd1dad6dec895c8d5c2dfdec9fbd5d2d395dcd4cd"><span class="__cf_email__" data-cfemail="f69c979b9385d885988f929384b6989f9ed8919980">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 20, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20493 Filed 9-25-17; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>


<ARTICLE>                                           UT
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM AMERICAN
UNITED GLOBAL, INC. YEAR ENDED JULY 31, 1997 AND IS QUALIFIED IN ITS' ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              JUL-31-1997
<PERIOD-START>                                 AUG-01-1996
<PERIOD-END>                                   JUL-31-1997
<BOOK-VALUE>                                   PRO-FORMA
<TOTAL-NET-UTILITY-PLANT>                      9,530,000
<OTHER-PROPERTY-AND-INVEST>                    8,582,000
<TOTAL-CURRENT-ASSETS>                         124,179,000
<TOTAL-DEFERRED-CHARGES>                       2,432,000
<OTHER-ASSETS>                                 0
<TOTAL-ASSETS>                                 144,723,000
<COMMON>                                       104,000
<CAPITAL-SURPLUS-PAID-IN>                      48,782,000
<RETAINED-EARNINGS>                            (24,600,000)
<TOTAL-COMMON-STOCKHOLDERS-EQ>                 24,101,000
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    11,000
<LONG-TERM-DEBT-NET>                           3,456,000
<SHORT-TERM-NOTES>                             67,241,000
<LONG-TERM-NOTES-PAYABLE>                      0
<COMMERCIAL-PAPER-OBLIGATIONS>                 0
<LONG-TERM-DEBT-CURRENT-PORT>                  0
<PREFERRED-STOCK-CURRENT>                      0
<CAPITAL-LEASE-OBLIGATIONS>                    4,026,000
<LEASES-CURRENT>                               412,000
<OTHER-ITEMS-CAPITAL-AND-LIAB>                 45,487,000
<TOT-CAPITALIZATION-AND-LIAB>                  143,547,000
<GROSS-OPERATING-REVENUE>                      154,545,000
<INCOME-TAX-EXPENSE>                           (1,669,000)
<OTHER-OPERATING-EXPENSES>                     12,510,000
<TOTAL-OPERATING-EXPENSES>                     165,533,000
<OPERATING-INCOME-LOSS>                        (23,077,000)
<OTHER-INCOME-NET>                             (421,000)
<INCOME-BEFORE-INTEREST-EXPEN>                 (23,077,000)
<TOTAL-INTEREST-EXPENSE>                       3,025,000
<NET-INCOME>                                   (26,102,000)
<PREFERRED-STOCK-DIVIDENDS>                    2,403,000
<EARNINGS-AVAILABLE-FOR-COMM>                  (27,257,000)
<COMMON-STOCK-DIVIDENDS>                       0
<TOTAL-INTEREST-ON-BONDS>                      0
<CASH-FLOW-OPERATIONS>                         (15,173,000)
<EPS-PRIMARY>                                  (2.75)
<EPS-DILUTED>                                  (2.75)
<FN>
<F1> TAG 41 REPRESENTS MINORITY INTEREST.
</FN>
        


</TABLE>
<PAGE>   1
              INDEPENDENT AUDITORS' REPORT ON SCHEDULE AND CONSENT

The Board of Directors and Stockholders
BioSource International, Inc.

The audits referred to in our report dated February 20, 1997 included the
related financial statement schedule for each of the years in the three-year
period ended December 31, 1996, included in the registration statement of
BioSource International, Inc. This financial statement schedule is the
responsibility of the Company's management. Our responsibility is to express an
opinion on this financial statement schedule based on our audits. In our
opinion, such financial statement schedule, when considered in relation to the
basic consolidated financial statements taken as a whole, presents fairly in
all material respects the information set forth therein.

We consent to incorporation by reference in the registration statement (No.
333-05391) on Form S-3 and the registration statements (Nos. 33-65562,
33-91838) on Form S-8 of BioSource International, Inc. of our report dated
February 20, 1997, relating to the consolidated balance sheets of BioSource
International, Inc. and subsidiaries as of December 31, 1996 and 1995 and the
related consolidated statements of operations, stockholders' equity and cash
flows and related schedule for each of the years in the three-year period ended
December 31, 1996, which report appears in the December 31, 1996 annual report
on Form 10-K of BioSource International, Inc.

                                        KPMG Peat Marwick LLP

Los Angeles, California
April 10, 1997
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 99-6314

KEVIN HARDY,

Petitioner - Appellant,

versus

WARDEN, Maryland House of Corrections - Annex,

Respondent - Appellee.

Appeal from the United States District Court for the District of

Maryland, at Greenbelt. Deborah K. Chasanow, District Judge. (CA98-2590-DKC)

Submitted: June 17, 1999 Decided: June 23, 1999

Before MURNAGHAN and TRAXLER, Circuit Judges, and BUTZNER, Senior

Circuit Judge.

Dismissed by unpublished per curiam opinion.

Kevin Hardy, Appellant Pro Se. John Joseph Curran, Jr., Attorney

General, David Jonathan Taube, Assistant Attorney General, Ann

Norman Bosse, OFFICE OF THE ATTORNEY GENERAL OF MARYLAND, Baltimore, Maryland, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Kevin Hardy filed an untimely notice of appeal. We dismiss

for lack of jurisdiction. The time periods for filing notices of

appeal are governed by Fed. R. App. P. 4. These periods are "mandatory and jurisdictional." Browder v. Director, Dep't of Corrections, 434 U.S. 257, 264 (1978) (quoting United States v. Robinson,

361 U.S. 220, 229 (1960)). Parties to civil actions have thirty

days within which to file in the district court notices of appeal

from judgments or final orders. Fed. R. App. P. 4(a)(1). The only

exceptions to the appeal period are when the district court extends

the time to appeal under Fed. R. App. P. 4(a)(5) or reopens the

appeal period under Fed. R. App. P. 4(a)(6).

The district court entered its order on January 4, 1999; Hardy

asserts that he gave his notice of appeal to a prison officer for

mailing on February 16, 1999, which is beyond the thirty-day appeal

period. Hardy's failure to note a timely appeal or obtain an

extension of the appeal period leaves this court without jurisdiction to consider the merits of his appeal. We therefore deny a

certificate of appealability and dismiss the appeal. We dispense

with oral argument because the facts and legal contentions are

adequately presented in the materials before the court and argument

would not aid the decisional process.

DISMISSED
<PAGE>

EXHIBIT 99.1

                  CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND
                             CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the quarterly report on Form 10-QSB of netGuru, Inc.
(the "Company") for the quarterly period ended December 31, 2002 (the "Report"),
the undersigned hereby certifies in his capacity as Chief Executive Officer of
the Company, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:

         1. the Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

         2. the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: February 19, 2003                    By: /s/ Amrit K. Das
                                                -----------------------
                                                Amrit K. Das
                                                Chief Executive Officer

         In connection with the quarterly report on Form 10-QSB of netGuru, Inc.
(the "Company") for the quarterly period ended December 31, 2002 (the "Report"),
the undersigned hereby certifies in his capacity as Chief Financial Officer of
the Company, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:

         1. the Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

         2. the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: February 19, 2003                    By: /s/ Bruce K. Nelson
                                                -----------------------
                                                Bruce K. Nelson
                                                Chief Financial Officer
Order entered January 30, 2014

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-13-00869-CV

RODNEY SHARP AND ALL OCCUPANTS, Appellant

V.

WOODRIDGE PROPERTIES COMPANY LP, Appellee

On Appeal from the County Court at Law No. 3

Dallas County, Texas

Trial Court Cause No. CC-13-00238-C

ORDER

The reporter’s record in this case has not been filed. By order dated January 17, 2014, 

the Court advised appellants that the Court would submit this appeal without a reporter’s record 

upon receiving verification either that (1) no request for the record has been made or (2) 

appellant is not indigent and has not paid for the reporter’s record. By letter received by the 

Court on January 28, 2014, Janet E. Wright, Court Reporter of Dallas County Court at Law No. 

3, advised the Court that she had not received a request for the reporter’s record from appellants. 

Accordingly, the Court ORDERS this case submitted without the reporter’s record. Within 

THIRTY (30) DAYS of the date of this order, appellant shall file their brief. We notify 
appellants that failure to file a brief in this case will result in dismissal for want of prosecution. 

See Tex. R. App. P. 38.8(a)(1).

/s/ CAROLYN WRIGHT

CHIEF JUSTICE
* Pursuant to 5 TH C IR . R. 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 96-11542 Summary Calendar

JERRY C. SMITH, Plaintiff-Appellant,

versus FRANK POHLMEIER, Captain; JOHN SIMMS, Dr.; ARYN HALE, Defendants-Appellees.

- - - - - - - - - - Appeal from the United States District Court for the Northern District of Texas

USDC No. 2:95-CV-317

- - - - - - - - - - November 19, 1997 Before KING, HIGGINBOTHAM, and DAVIS, Circuit Judges. PER CURIAM: * Jerry C. Smith, Texas prisoner #620930, appeals the dismissal of his 42 U.S.C. § 1983 complaint for failure to state a claim upon which relief can be granted and frivolousness. Smith argues that the defendants used excessive force and forcefully medicated him with a drug to which he is allergic.2

We have reviewed the record and Smith’s brief and AFFIRM the district court’s dismissal for essentially the same reasons adopted by the district court. Smith v. Pohlmeier , No. 2:95-CV317 (N.D. Tex. Nov. 27, 1996). AFFIRMED.
**Exhibit** **32.1**

 

**ANTARES PHARMA, INC.**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)**

 

The undersigned, Dr. Paul K. Wotton, the Chief Executive Officer of Antares Pharma, Inc. (the “Company”), has executed this Certification in connection with the filing with the Securities and Exchange Commission of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2009 (the “Report”).

 

The undersigned hereby certifies that:

 

|   | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------|

 

IN WITNESS WHEREOF, the undersigned has executed this Certification as of the 13th day of August, 2009.

 

|   |   |   |   | /s/ Paul K. Wotton                                        |
|--------|--------|--------|--------|-----------------------------------------------------------|
|   |   |   |   | Dr. Paul K. Wotton

President and Chief Executive Officer |
|   |   |   |   |                                                      |
EXHIBIT 32.1



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Mark Gustafson, President, Secretary and Treasurer of Torrent Energy Corporation., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	the Annual Report on Form 10-KSB of Torrent Energy Corporation. for the year ended March 31, 2004 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Torrent Energy Corporation.

Dated:  November 15, 2004

/s/ Mark Gustafson					
Mark Gustafson
President, Secretary and Treasurer
(Principal Executive and Principal Financial Officer)
EXHIBIT
32-2
 
 CERTIFICATION
PURSUANT TO
 18 U.S.C.
SECTION 1350,
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In
connection with the Annual Report on Form 10-K of WNC Housing Tax Credit Fund
II, L.P. (the “Partnership”) for the year ended March 31, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), and
pursuant to 18 U.S.C., section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002, I, Melanie R. Wenk, Chief Financial Officer of WNC
& Associates, Inc., general partner of the Partnership, hereby certify
that:
 
 1.
              The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and
 
 2.
              The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and result of operations of the
      Partnership.
 
 
 /s/MELANIE R.
WENK
  Melanie
R. Wenk
 Vice
President and Chief Financial Officer of WNC & Associates, Inc.
 
 Date:
June 29, 2010
Increasing Lender Agreement, dated as of April 6, 2018, by Citibank, N.A.


 Exhibit 10.1 

EXECUTION COPY 
 INCREASING
LENDER AGREEMENT 
 INCREASING LENDER AGREEMENT dated as of April 6, 2018 by Citibank, N.A. (the “Increasing
Lender”) in favor of Goldman Sachs Middle Market Lending Corp., a Delaware corporation (the “Borrower”), and SunTrust Bank, as administrative agent under the Credit Agreement referred to below (in such capacity, together
with its successors in such capacity, the “Administrative Agent”). 
 The Borrower, the Lenders (including
the Increasing Lender) from time to time party thereto and the Administrative Agent are parties to a Senior Secured Revolving Credit Agreement, dated as of September 11, 2017 (as amended, supplemented or otherwise modified and in effect from
time to time, the “Credit Agreement”). 
 Pursuant to Section 2.08(e) of the
Credit Agreement, the Increasing Lender hereby agrees to increase its Multicurrency Commitment from $25,000,000 to $50,000,000. 

Sections 9.06, 9.09 and 9.10 of the Credit Agreement apply to this Increasing Lender Agreement mutatis mutandis. 

IN WITNESS WHEREOF, the Increasing Lender has caused this Increasing Lender Agreement to be duly executed and delivered as of
the day and year first above written. 







			
	CITIBANK, N.A.
	as Increasing Lender


			
		
	By:	 	 /s/ Erik Andersen



			
	Name: Erik Andersen
	Title:   Vice President







 Accepted and agreed: 
  

			
	GOLDMAN SACHS MIDDLE MARKET
	LENDING CORP.,
	as Borrower


			
		
	By:	 	 /s/ Jonathan Lamm



			
	Name: Jonathan Lamm
	Title: Authorized Signatory








			
	SUNTRUST BANK,
	as Administrative Agent


			
		
	By:	 	 /s/ Doug Kennedy



			
	Name:  Doug Kennedy
	Title:    Director
EXHIBIT 32.2

           WRITTEN STATEMENT FURNISHED PURSUANT TO SECTION 906 OF THE
               SARBANES-OXLEY ACT OF 2002, 18 U.S.C. SECTION 1350

         The undersigned, William C. Gray, is the Senior Vice President and
Chief Financial Officer of Carver Bancorp, Inc. (the "Company").

         This statement is being furnished in connection with the filing by the
Company of the Company's Quarterly Report on Form 10-Q for the quarter ended
September 30, 2003 (the "Report").

         By execution of this statement, I certify that:

         a)       the Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934 (15
                  U.S.C. 78m(a) or 78o(d)); and

         b)       the information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company as of the dates and for the periods
                  covered by the Report.



November 14, 2003                                    /s/ William C. Gray
-----------------                                    -------------------
Dated                                                William C. Gray






                                       33
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3025 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 3025

 To provide for certain tunnel life safety and rehabilitation projects 
                              for Amtrak.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 22, 2011

  Mr. King of New York (for himself, Mr. Pascrell, Mr. Grimm, and Mr. 
 Turner of New York) introduced the following bill; which was referred 
         to the Committee on Transportation and Infrastructure

_______________________________________________________________________

                                 A BILL

 
 To provide for certain tunnel life safety and rehabilitation projects 
                              for Amtrak.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Northeast Corridor Rail Tunnel 
Safety Act''.

SEC. 2. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated to the Secretary of 
Transportation $898,000,000, to remain available until expended, for 
the use of Amtrak to complete New York tunnel life safety projects and 
to rehabilitate tunnels in Washington, DC, and Baltimore, Maryland.

SEC. 3. AVAILABILITY OF FUNDS.

    The Secretary shall not make funds appropriated under section 2 
available to Amtrak for a project unless the Secretary has received 
from Amtrak and has approved an engineering and financial plan for that 
project.

SEC. 4. INSPECTOR GENERAL REVIEW.

    The Inspector General of the Department of Transportation shall 
conduct and transmit to the Congress an annual review to determine 
whether the expenditure and obligation of funds made available under 
this Act are consistent with the purposes for which those funds are 
made available.
                                 <all>
```